Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Carbon-14
1.2.3 Technetium-99m
1.2.4 Iodine-131
1.2.5 Iodine-125
1.2.6 Others
1.3 Market by Application
1.3.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Nuclear Medicine Diagnosis
1.3.3 Nuclear Medicine Treatment
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Perspective (2021–2032)
2.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Growth Trends by Region
2.2.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Historic Market Size by Region (2021–2026)
2.2.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Region (2027–2032)
2.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Dynamics
2.3.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Industry Trends
2.3.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers
2.3.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Challenges
2.3.4 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Revenue (2021–2026)
3.1.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Players (2021–2026)
3.2 Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue
3.4 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue in 2025
3.5 Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment Head Offices and Areas Served
3.6 Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Products and Applications
3.7 Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Breakdown Data by Type
4.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Historic Market Size by Type (2021–2026)
4.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Type (2027–2032)
5 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Breakdown Data by Application
5.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Historic Market Size by Application (2021–2026)
5.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2021–2032)
6.2 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2021–2026)
6.4 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2021–2032)
7.2 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2021–2026)
7.4 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2021–2032)
8.2 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2021–2026)
8.4 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2021–2032)
9.2 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2021–2026)
9.4 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2021–2032)
10.2 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2021–2026)
10.4 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NRG
11.1.1 NRG Company Details
11.1.2 NRG Business Overview
11.1.3 NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.1.4 NRG Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
11.1.5 NRG Recent Development
11.2 NTP Radioisotopes
11.2.1 NTP Radioisotopes Company Details
11.2.2 NTP Radioisotopes Business Overview
11.2.3 NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.2.4 NTP Radioisotopes Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
11.2.5 NTP Radioisotopes Recent Development
11.3 JSC Isotope
11.3.1 JSC Isotope Company Details
11.3.2 JSC Isotope Business Overview
11.3.3 JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.3.4 JSC Isotope Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
11.3.5 JSC Isotope Recent Development
11.4 ANSTO
11.4.1 ANSTO Company Details
11.4.2 ANSTO Business Overview
11.4.3 ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.4.4 ANSTO Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
11.4.5 ANSTO Recent Development
11.5 China National Nuclear Corporation (CNNC)
11.5.1 China National Nuclear Corporation (CNNC) Company Details
11.5.2 China National Nuclear Corporation (CNNC) Business Overview
11.5.3 China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.5.4 China National Nuclear Corporation (CNNC) Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
11.5.5 China National Nuclear Corporation (CNNC) Recent Development
11.6 IRE ELIT
11.6.1 IRE ELIT Company Details
11.6.2 IRE ELIT Business Overview
11.6.3 IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.6.4 IRE ELIT Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
11.6.5 IRE ELIT Recent Development
11.7 Nordion
11.7.1 Nordion Company Details
11.7.2 Nordion Business Overview
11.7.3 Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.7.4 Nordion Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
11.7.5 Nordion Recent Development
11.8 Polatom
11.8.1 Polatom Company Details
11.8.2 Polatom Business Overview
11.8.3 Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction
11.8.4 Polatom Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
11.8.5 Polatom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Carbon-14
Table 3. Key Players of Technetium-99m
Table 4. Key Players of Iodine-131
Table 5. Key Players of Iodine-125
Table 6. Key Players of Others
Table 7. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (US$ Million), 2021–2026
Table 10. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region (2021–2026)
Table 11. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region (2027–2032)
Table 13. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Trends
Table 14. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers
Table 15. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Challenges
Table 16. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints
Table 17. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue by Players (US$ Million), 2021–2026
Table 18. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Players (2021–2026)
Table 19. Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, 2025
Table 20. Ranking of Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Headquarters and Area Served
Table 23. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Products and Applications
Table 24. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Type (US$ Million), 2021–2026
Table 27. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Type (2021–2026)
Table 28. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Type (2027–2032)
Table 30. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application (US$ Million), 2021–2026
Table 31. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Application (2021–2026)
Table 32. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Application (2027–2032)
Table 34. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (US$ Million), 2021–2026
Table 36. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (US$ Million), 2027–2032
Table 49. NRG Company Details
Table 50. NRG Business Overview
Table 51. NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 52. NRG Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (US$ Million), 2021–2026
Table 53. NRG Recent Development
Table 54. NTP Radioisotopes Company Details
Table 55. NTP Radioisotopes Business Overview
Table 56. NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 57. NTP Radioisotopes Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (US$ Million), 2021–2026
Table 58. NTP Radioisotopes Recent Development
Table 59. JSC Isotope Company Details
Table 60. JSC Isotope Business Overview
Table 61. JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 62. JSC Isotope Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (US$ Million), 2021–2026
Table 63. JSC Isotope Recent Development
Table 64. ANSTO Company Details
Table 65. ANSTO Business Overview
Table 66. ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 67. ANSTO Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (US$ Million), 2021–2026
Table 68. ANSTO Recent Development
Table 69. China National Nuclear Corporation (CNNC) Company Details
Table 70. China National Nuclear Corporation (CNNC) Business Overview
Table 71. China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 72. China National Nuclear Corporation (CNNC) Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (US$ Million), 2021–2026
Table 73. China National Nuclear Corporation (CNNC) Recent Development
Table 74. IRE ELIT Company Details
Table 75. IRE ELIT Business Overview
Table 76. IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 77. IRE ELIT Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (US$ Million), 2021–2026
Table 78. IRE ELIT Recent Development
Table 79. Nordion Company Details
Table 80. Nordion Business Overview
Table 81. Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 82. Nordion Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (US$ Million), 2021–2026
Table 83. Nordion Recent Development
Table 84. Polatom Company Details
Table 85. Polatom Business Overview
Table 86. Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product
Table 87. Polatom Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (US$ Million), 2021–2026
Table 88. Polatom Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report


List of Figures
Figure 1. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Picture
Figure 2. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Type: 2025 vs 2032
Figure 4. Carbon-14 Features
Figure 5. Technetium-99m Features
Figure 6. Iodine-131 Features
Figure 7. Iodine-125 Features
Figure 8. Others Features
Figure 9. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Application: 2025 vs 2032
Figure 11. Nuclear Medicine Diagnosis Case Studies
Figure 12. Nuclear Medicine Treatment Case Studies
Figure 13. Others Case Studies
Figure 14. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Report Years Considered
Figure 15. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region: 2025 vs 2032
Figure 18. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Players in 2025
Figure 19. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue in 2025
Figure 21. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2021–2032)
Figure 23. United States Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2021–2032)
Figure 27. Germany Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region (2021–2032)
Figure 35. China Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2021–2032)
Figure 43. Mexico Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2021–2032)
Figure 47. Israel Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. NRG Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
Figure 51. NTP Radioisotopes Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
Figure 52. JSC Isotope Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
Figure 53. ANSTO Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
Figure 54. China National Nuclear Corporation (CNNC) Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
Figure 55. IRE ELIT Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
Figure 56. Nordion Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
Figure 57. Polatom Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2021–2026)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed